Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

Overview of attention for article published in Arthritis Research & Therapy, June 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 9,779 followers.

20 June 2012 Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis https://t.co/9NSvDMZFOh

01 Oct 2023

Reply Repost Favourite

RT @philipcrobinson: Really interesting piece on a protease inhibitor in ReA from Robert Inman in @ArthritisRes via @arthritis_bio http://t.co/N96gxXYU

25 Jun 2012

Reply Repost Favourite

Really interesting piece on a protease inhibitor in ReA from Robert Inman in @ArthritisRes via @arthritis_bio http://t.co/N96gxXYU

23 Jun 2012

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.